1. Home
  2. DIOD vs CELC Comparison

DIOD vs CELC Comparison

Compare DIOD & CELC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DIOD
  • CELC
  • Stock Information
  • Founded
  • DIOD 1959
  • CELC 2011
  • Country
  • DIOD United States
  • CELC United States
  • Employees
  • DIOD 8593
  • CELC N/A
  • Industry
  • DIOD Semiconductors
  • CELC Medical Specialities
  • Sector
  • DIOD Technology
  • CELC Health Care
  • Exchange
  • DIOD Nasdaq
  • CELC Nasdaq
  • Market Cap
  • DIOD 2.5B
  • CELC 2.3B
  • IPO Year
  • DIOD N/A
  • CELC 2017
  • Fundamental
  • Price
  • DIOD $51.02
  • CELC $48.83
  • Analyst Decision
  • DIOD Buy
  • CELC Strong Buy
  • Analyst Count
  • DIOD 2
  • CELC 6
  • Target Price
  • DIOD $57.50
  • CELC $63.00
  • AVG Volume (30 Days)
  • DIOD 426.7K
  • CELC 1.0M
  • Earning Date
  • DIOD 11-06-2025
  • CELC 11-13-2025
  • Dividend Yield
  • DIOD N/A
  • CELC N/A
  • EPS Growth
  • DIOD N/A
  • CELC N/A
  • EPS
  • DIOD 1.37
  • CELC N/A
  • Revenue
  • DIOD $1,387,702,000.00
  • CELC N/A
  • Revenue This Year
  • DIOD $14.48
  • CELC N/A
  • Revenue Next Year
  • DIOD $8.39
  • CELC N/A
  • P/E Ratio
  • DIOD $38.71
  • CELC N/A
  • Revenue Growth
  • DIOD 2.86
  • CELC N/A
  • 52 Week Low
  • DIOD $32.93
  • CELC $7.58
  • 52 Week High
  • DIOD $67.40
  • CELC $63.06
  • Technical
  • Relative Strength Index (RSI)
  • DIOD 40.93
  • CELC 49.33
  • Support Level
  • DIOD $50.95
  • CELC $44.42
  • Resistance Level
  • DIOD $53.93
  • CELC $50.74
  • Average True Range (ATR)
  • DIOD 1.66
  • CELC 3.02
  • MACD
  • DIOD -0.29
  • CELC -1.06
  • Stochastic Oscillator
  • DIOD 2.93
  • CELC 40.61

About DIOD Diodes Incorporated

Diodes Inc is a manufacturer and supplier of high-quality application-specific products within the broad discrete, logic, analog, and mixed-signal semiconductor markets. It serves the customer electronics, computing, communications, industrial, and automotive markets. The Company's products include diodes; rectifiers; transistors; MOSFETs; GPP bridges; GPP rectifiers; protection devices; function-specific arrays; single gate logic; amplifiers and comparators; Hall-effect and temperature sensors; and power management devices, including LED drivers, AC-DC converters and controllers, DC-DC switching and linear voltage regulators, voltage references along with special-function devices, such as USB power switches, load switches, voltage supervisors, and motor controllers.

About CELC Celcuity Inc.

Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.

Share on Social Networks: